We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

111 hedge funds and large institutions have $5.41M invested in Ampio Pharmaceuticals Inc. in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 26 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,280% more call options, than puts

Call options by funds: $207K | Put options by funds: $15K

13% less funds holding

Funds holding: 128 → 111 (-17)

38% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 26

43% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 30

76% less capital invested

Capital invested by funds: $22.8M → $5.41M (-$17.3M)

Holders
111
Holders Change
-17
Holders Change %
-13.28%
% of All Funds
1.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
16
Reduced
26
Closed
30
Calls
$207K
Puts
$15K
Net Calls
+$192K
Net Calls Change
-$405K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$459K
2
E
Ergoteles
New York
+$238K
3
Citadel Advisors
Citadel Advisors
Florida
+$159K
4
VF
Virtu Financial
New York
+$106K
5
Morgan Stanley
Morgan Stanley
New York
+$52.8K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.31M
2
WIC
Willis Investment Counsel
Georgia
-$976K
3
State Street
State Street
Massachusetts
-$698K
4
Renaissance Technologies
Renaissance Technologies
New York
-$454K
5
Northern Trust
Northern Trust
Illinois
-$344K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
51
Two Sigma Investments
New York
$11K +$16.1K +216 New
IWM
52
IHT Wealth Management
Illinois
$10K – – –
SBIA
53
Sheaff Brock Investment Advisors
Indiana
$10K – – –
GWM
54
Geneos Wealth Management
Colorado
$9K – – –
Verition Fund Management
55
Verition Fund Management
Connecticut
$9K +$13K +175 New
FHA
56
Flagship Harbor Advisors
Massachusetts
$8K – – –
UBS Group
57
UBS Group
Switzerland
$8K +$10K +135 +794%
TSS
58
Two Sigma Securities
New York
$8K +$12.4K +166 New
SFG
59
SNS Financial Group
Minnesota
$7K – – –
Citigroup
60
Citigroup
New York
$7K +$6.77K +91 +198%
TW
61
Transform Wealth
Colorado
$6K -$17.2K -231 -68%
JWA
62
JFS Wealth Advisors
Pennsylvania
$6K – – –
BNP Paribas Financial Markets
63
BNP Paribas Financial Markets
France
$5.86K +$4.39K +59 +104%
Victory Capital Management
64
Victory Capital Management
Texas
$5K -$74 -1 -1%
Commonwealth Equity Services
65
Commonwealth Equity Services
Massachusetts
$5K – – –
CCB
66
Cutter & Co Brokerage
Missouri
$5K – – –
YIH
67
Y-Intercept (HK)
Hong Kong
$5K +$6.85K +92 New
SIG
68
Stonegate Investment Group
Alabama
$5K +$7.44K +100 New
Balyasny Asset Management
69
Balyasny Asset Management
Illinois
$5K +$8.04K +108 New
EWA
70
Exencial Wealth Advisors
Oklahoma
$4K -$3.2K -43 -34%
OC
71
Oppenheimer & Co
New York
$4K -$74 -1 -1%
ACM
72
Avalon Capital Management
California
$4K – – –
BCM
73
Brookstone Capital Management
Illinois
$4K – – –
CW
74
CreativeOne Wealth
Kansas
$4K – – –
MFA
75
Mayflower Financial Advisors
Massachusetts
$4K – – –
1 2
3
4 5

AMPE Hedge Fund Activity: Q2 2022 in Review

111 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2022, worth a combined $5.41M — down 76% from $22.8M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of AMPE and 17 opened new positions — a net loss of 13 holders — while 26 trimmed existing stakes and 16 added.

The largest buyer was Millennium Management, adding an estimated $459K. The largest seller was BlackRock, cutting an estimated $2.31M.

  • 111 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2022, down from 128 in Q1 2022.
  • Funds reported $5.41M of Ampio Pharmaceuticals Inc. stock for Q2 2022, down 76% quarter-over-quarter.
  • 17 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2022 and 30 closed out, a net change of -13 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q2 2022 was Millennium Management, an estimated $459K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q2 2022 was BlackRock, an estimated $2.31M sold.

Based on aggregated 13F filings for Q2 2022.